Skip to main content
OXFORD NANOPORE TECHNOLOGIES PLC logo

OXFORD NANOPORE TECHNOLOGIES PLC — Investor Relations & Filings

Ticker · ONT ISIN · GB00BP6S8Z30 LEI · 213800IRWQ2Q6M2CDW55 IL Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2022-06-13 Remuneration Information
Country GB United Kingdom
Listing IL ONT

About OXFORD NANOPORE TECHNOLOGIES PLC

https://nanoporetech.com/

Oxford Nanopore Technologies PLC develops and commercializes a proprietary technology platform for DNA and RNA sequencing. The company's core technology is based on nanopore sensing, which enables the direct, real-time analysis of single molecules. This electronic method facilitates the sequencing of native nucleic acids, generating long-read data without requiring amplification. The platform is uniquely scalable, offering a range of products from portable, pocket-sized devices like the MinION to high-throughput instruments for population-scale projects. This technology provides researchers with immediate access to data, enabling rapid insights across various fields of biological research, including human genetics, cancer research, microbiology, and environmental science.

Recent filings

Filing Released Lang Actions
Share Incentive Plan - Director/PDMR Shareholding
Remuneration Information Classification · 99% confidence The document is an RNS (Regulatory News Service) announcement from Oxford Nanopore Technologies plc, dated June 13, 2022. The content explicitly details transactions made by Persons Discharging Managerial Responsibilities (PDMRs) regarding the company's shares under a Share Incentive Plan (SIP). This type of filing, which reports personal share transactions by directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). The document also references Article 19(3) of the UK Market Abuse Regulation, confirming its regulatory nature regarding insider transactions.
2022-06-13 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change Classification · 98% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service), which is explicitly mentioned as the news service of the London Stock Exchange and an FCA Primary Information Provider. The content details the 'Issue of Equity and Total Voting Rights' following option exercises and share plan issuances, and it explicitly states the total number of voting rights as of May 31, 2022, for FCA disclosure purposes. This type of mandatory disclosure regarding share capital changes and voting rights fits best under 'Share Issue/Capital Change' (SHA) or, given the context of being a general regulatory announcement provided via RNS, it could also be considered a general 'Regulatory Filing' (RNS). However, since the core subject is the change in the number of shares and voting rights, SHA is more specific. Since the document is short and is a direct notification of a capital structure event, SHA is the most appropriate specific code. The document length is short (2830 chars), but it contains the substantive information rather than just announcing another report, thus avoiding the RPA classification.
2022-06-01 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Director/PDMR Notification' and details the purchase of shares and exercise of options by persons discharging managerial responsibilities (PDMRs), specifically a Non-executive Director and the Chief Technology Officer. This type of filing, reporting insider transactions, directly corresponds to the definition of Director's Dealing. The presence of 'RNS Number' and references to Article 19 of the UK Market Abuse Regulation confirms it is a regulatory disclosure related to insider trading, fitting the 'DIRS' code.
2022-05-31 English
ONT releases Remora:most comprehensive methylation
Regulatory Filings Classification · 100% confidence The document is identified by the header 'RNS Number : 8443M' and contains the footer text indicating it is distributed via 'Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' The content describes a product update ('Remora' integration into MinKNOW software) and includes quotes and links to presentations, which is characteristic of a general company announcement or press release rather than a formal regulatory filing like a 10-K, AR, or IR. Since it is explicitly stated to be a non-regulatory press release distributed via RNS's Reach service, and it doesn't fit specific categories like ER, DIV, or CAP, the most appropriate general classification for a non-regulatory announcement that is not a standard report is Regulatory Filings (RNS), which serves as the fallback for miscellaneous announcements not covered elsewhere, especially when distributed through the RNS system.
2022-05-26 English
Oxford Nanopore announces tech updates
Environmental & Social Information Classification · 99% confidence The document is identified by the RNS Number '1839M' and is dated May 20, 2022. The content is a detailed update on technology advancements (sequencing chemistry, flow cells, devices like PromethION 2, software like Dorado and MinKNOW) presented at the 'London Calling conference'. This is a corporate announcement providing operational and technological progress updates, not a formal regulatory financial filing like a 10-K or an Earnings Release (ER). Since it is a specific corporate update distributed via RNS, and it is not a standard financial report, dividend notice, or management change, it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a broad category for non-standard regulatory news releases. The presence of the 'Reach' disclaimer further confirms it is a general news distribution, not a primary regulatory filing, making RNS the most appropriate catch-all.
2022-05-20 English
ONT opens user conference, rich science programme
Regulatory Filings Classification · 99% confidence The document is an announcement released via RNS (RNS Number: 0929M) on May 19, 2022. The content describes the opening of the company's annual 'London Calling' conference, detailing the scientific presentations and research highlights (genomics, cancer research, etc.). It is not a formal regulatory report like a 10-K or an IR, nor is it a transcript of a call (CT). It is an update about a company event and its associated scientific content, which is often distributed as a general press release or regulatory news service update. Since it details an event and its content rather than announcing a financial result (ER) or a formal meeting vote (AGM-R), and it is distributed via RNS, it fits best under the general Regulatory Filings (RNS) category, as it is a broad announcement distributed through the regulatory news service, even if the content itself is promotional/informational about a conference.
2022-05-19 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.